Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2020

Nov 10, 2020

SELL
$1.5 - $9.38 $167,676 - $1.05 Million
-111,784 Closed
0 $0
Q2 2020

Aug 13, 2020

BUY
$4.79 - $8.39 $535,445 - $937,867
111,784 New
111,784 $938,000
Q3 2018

Nov 14, 2018

SELL
$4.65 - $7.95 $71,563 - $122,350
-15,390 Closed
0 $0
Q2 2018

Aug 14, 2018

BUY
$5.05 - $6.8 $77,719 - $104,652
15,390 New
15,390 $78,000

Others Institutions Holding CRBP

About Corbus Pharmaceuticals Holdings, Inc.


  • Ticker CRBP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 125,268,000
  • Market Cap $1.12B
  • Description
  • Corbus Pharmaceuticals Holdings, Inc., a biopharmaceutical company, focuses on the development of immune modulators for immuno-oncology and fibrosis diseases. It develops lenabasum, an oral molecule that selectively activates cannabinoid receptor type 2 (CB2), which is in Phase II clinical trial to treat systemic lupus erythematosus; CRB-601, an...
More about CRBP
Track This Portfolio

Track Landscape Capital Management, L.L.C. Portfolio

Follow Landscape Capital Management, L.L.C. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Landscape Capital Management, L.L.C., based on Form 13F filings with the SEC.

News

Stay updated on Landscape Capital Management, L.L.C. with notifications on news.